Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic [Phase 4]
Phase 4 trial evaluating conversion from tacrolimus to sirolimus in stable kidney transplant recipients on mycophenolic acid (Myfortic).
-
FDA approval · 2020-10-16FDA Approved: SIROLIMUS — Original Application (NORTHSTAR RX LLC)
FDA approved a generic sirolimus from NorthStar RX LLC under an Original Application (ANDA 208691) for use in preventing organ transplant re…
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Bela 8 Week Dosing [Phase 4]
Phase 4 clinical trial update for Bela 8-week dosing in kidney transplantation; study completed with results posted.
-
FDA approval · 2020-08-04FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for mycophenolate mofetil, a generic immunosuppressant used to prevent organ transplant rejecti…
-
FDA approval · 2020-08-04FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Mycophenolate mofetil filed by Strides Pharma Science Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: RituxiMab INDuction in Renal Transplantation [Phase 4]
Phase 4 trial update for RituxiMab induction therapy in renal transplantation; status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial comparing immediate-release tacrolimus (Prograf) and Astagraf XL to assess donor-specific antibody formation and immu…
-
FDA approval · 2020-06-08FDA Approved: EVEROLIMUS — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic Everolimus under an Original Application, enabling the sale of a generic version of th…
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Veloxis de Novo Kidney Transplant ECSWD [Phase 4]
A Phase 4 clinical trial update for Veloxis involving de novo kidney transplant patients, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Measurements of Kidney Perfusion After Transplantation by Intraoperative Fluorescence Angiography [Phase 2]
Phase 2 clinical trial assessing measurements of kidney perfusion after transplantation using intraoperative fluorescence angiography.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Study of Rituximab to Treat Chronic Renal Transplant Rejection [Phase 4]
A Phase 4 trial evaluating rituximab for chronic renal transplant rejection has been completed.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys? [Phase 4]
Phase 4 clinical trial investigating whether contrast-enhanced ultrasound (CEUS) improves selection of biopsy sites in evaluating transplant…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients [Phase 4]
Phase 4 trial update describing dosing requirements of Astagraf XL in African American kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.
A completed clinical trial examined how functional genetic variants influence tacrolimus trough levels and related side effects in Chinese k…
-
FDA approval · 2019-10-22FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for tacrolimus (generic) under ANDA 091195, enabling continued approval of a …
-
CLINICAL_TRIALS research · 2019-10-08Clinical Trial Update: Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation [Phase 2]
Phase 2 clinical trial evaluating rituximab induction and living donation on immunoregulation and virus control in kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy [Phase 2, Phase 3]
Clinical trial updates on Campath and calcineurin inhibitor reduction for chronic allograft nephropathy in kidney transplantation have compl…
-
FDA approval · 2019-09-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolate mofetil. This action updates the regulatory status for th…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation [Phase 2]
Phase 2 pharmacogenetic trial of tacrolimus after pediatric transplantation completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus [Phase 4]
Phase 4 clinical trial investigating phenotypic drug probes as predictors of drug-drug interactions with tacrolimus in kidney transplant pat…
-
CLINICAL_TRIALS research · 2019-07-18Clinical Trial Update: The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria [Phase 4]
A Phase 4 trial comparing antibiotics versus no treatment to prevent symptomatic urinary tract infection in kidney transplant recipients wit…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation [Phase 2]
Phase 2 trial evaluating mycophenolic acid monotherapy in recipients of HLA-identical living-related kidney transplants; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients [Phase 4]
Phase 4 trial comparing tacrolimus hexal-based regimen vs Prograf-based regimen in de novo renal transplant recipients.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation [Phase 2]
Phase 2 trial of GSK1070806 for prevention of delayed graft function in adult kidney transplant recipients; study terminated with results po…
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study [Phase 2]
Phase 2 pharmacokinetic and clinical study of Envarsus once daily with Everolimus in elderly kidney transplant recipients has completed.